Texas Oncology-Weslaco

Weslaco, Texas 78596

1 studies enrolling now · 9 studies all time

What they study most

Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm, Cancer, Carcinoid Syndrome, Chronic Lymphocytic Leukemia (CLL), End Stage Cancer, Follicular Lymphoma, KEAP1 Gene Mutation, Kidney Neoplasms, Metastatic Breast Cancer, NFE2L2 Gene Mutation

Studies at this site

• Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. — Recruiting now
• A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. — Running, not enrolling
• Breast Cancer Index (BCI) Registry — Running, not enrolling
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• The Circulating Cell-free Genome Atlas Study — Status unconfirmed
• NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial — Stopped early
• informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed
• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed
• Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy — Completed